Eye manifestations of congenital toxoplasmosis

American Journal of Ophthalmology

Volumn 122, Issue 3, 1996, Pages 309-324

  Mets, M B ^a   Holfels, E ^a   Boyer, K M ^a   Swisher, C N ^a   Roizen, N ^a   Stein, L ^a   Stein, M ^a   Hopkins, J ^a   Withers, S ^a   Mack, D ^a   Luciano, R ^a   Patel, D ^a   Remington, J S ^a   Meier, P ^a   McLeod, R ^a  

^a MICHAEL REESE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SULFADIAZINE;

AMBLYOPIA; ARTICLE; CATARACT; CHORIORETINOPATHY; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA DETACHMENT; RISK FACTOR; VISUAL IMPAIRMENT;

EID: 0029737597     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)72057-4     Document Type: Article

References (48)

1. Eichenwald HG A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae, and therapy Siim JC Human toxoplasmosis 1960 Munksgaard Copenhagen, Denmark 41 49
2. Wilson CB Remington JS Stagno S Reynolds DW Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection Pediatrics 66 1980 767 774
3. Koppe JG Kloosterman GJ de Roever-Bonnet H Eckert-Stoink JA Loewer-Sieger DH de Braijue JI Toxoplasmosis and pregnancy, with a long-term follow-up of the children Eur J Obstet Gynecol Reprod Biol 413 1974 101 110
4. Koppe JG Loewer-Sieger DH deRoever-Bonnet H Results of 20 year follow-up of congenital toxoplasmosis Lancet 1 1986 254 256
5. Couvreur J Desmonts G Tournier G Szusterkac M Study of a homogenous series of 210 cases of congenital toxoplasmosis in infants aged 0 to 11 months detected prospectively Ann Pediatr 31 1984 815 819
6. Couvreur J Desmonts G Aron-Rosa D Le prognostic oculaire de la toxoplasmose congenitale: role du traitement Ann Pediatr 31 1984 855 858
7. McAuley JB Boyer KM Patel D Mets M Swisher C Roizen N Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial Clin Infect Dis 18 1994 38 72
8. Remington JS McLeod R Desmonts G Toxoplasmosis Remington JS Klein JO Infectious diseases of the fetus and newborn 4 1995 WB Saunders Philadelphia, Pennsylvania 140 267
9. Patel DV Holfels EM Vogel NP Boyer KM Mets MB Swisher CN Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis Radiology 199 1996 433 440
10. Mets MB, Toxoplasmosis Collaborative Study Group. Ophthalmologic findings in congenital toxoplasmosis. ARVO abstracts. Invest Ophthalmol Vis Sci 1992;33(4,suppl):1094.
11. Hogan MJ Kimura SJ Lewis A Zweigart PA Early and delayed ocular manifestations of congenital toxoplasmosis Trans Am Ophthalmol Soc 55 1957 275 296
12. Hogan MJ Kimura SJ O'Connor GR Ocular toxoplasmosis Clin Sci 72 1964 592 600
13. Hogan MJ Ocular toxoplasmosis Am J Ophthalmol 46 1958 467 494
14. Nussenblatt RB Belfort R Jr. Ocular toxoplasmosis: an old disease revisited JAMA 271 1994 304 307
15. Hohlfeld P Daffos F Thulliez P Aufrant C Couvreur J MacAleese J Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment J Pediatr 115 1989 765 769
16. Daffos F Forestier F Capella-Pavlovsky M Thulliez P Aufrant C Valenti D Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 318 1988 271 275
17. Labadie MD Hazemann JJ Aport desbilans de sante de l'enfant pour le dépistage et l'étude épidemiologique de la toxoplasmose congenitale Ann Pediatr 31 1984 823 828
18. Roberts T Murrell KD Marks S Economic losses caused by foodborne parasitic diseases Parasitol Today 10 1994 419 423
19. Roberts T Frenkel JK Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States JAMA 2 1990 249 256
20. Wilson CB Remington JS What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 138 1980 357 363
21. McLeod R Mack D Foss R Boyer K Withers S Levin S Levels of pyrimethamine in sera and cerebrospinal fluid and ventricular fluids from infants treated for congenital toxoplasmosis Antimicrob Agents Chemother 36 1992 1040 1048
22. Zar JH Biostatistical analysis 1974 Prentice Hall, Inc. Englewood Cliffs, New Jersey
23. McGee T Wolters C Stein L Kraus N Johnson D Boyer K Absence of sensorineural hearing abnormalities in treated infants with congenital toxoplasmosis Otolaryngol Head Neck Surg 106 1992 75 80
24. Roizen N Swisher C Stein M Hopkins J Boyer K Holfels E Neurologic and developmental outcome in treated congenital toxoplasmosis Pediatrics 95 1995 11 20
25. Swisher CN Boyer K McLeod R Congenital toxoplasmosis Semin Pediatr Neurol 1 1994 4 25
26. Sibalic D Djurkovic-Djakovic O Bobic B Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 9 1990 671 674
27. Brezin AP Kasner L Thulliez P Li Q Daffos F Nussenblatt RB Ocular toxoplasmosis in the fetus: immunohistochemistry analysis and DNA amplification Retina 14 1994 19 26
28. Gazzinelli RT Brezin A Li Q Nussenblatt RB Chan C Toxoplasma gondii : acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ Exp Parasitol 78 1994 217 229
29. McMenamin PG Dutton GN Hay J Cameron S The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis, part 1: the localization and morphology of toxoplasma cysts in the retina Exp Eye Res 43 1986 529 543
30. Malla N Goyal M Pillai P Ganguly NK Mahajan RC Experimental ocular toxoplasmosis with RH strain of Toxoplasma gondii J Exp Med 58 1988 279 281
31. Jacobs L Melton ML Kaufman H Treatment of experimental ocular toxoplasmosis Arch Ophthalmol 71 1964 145 152
32. Holland GN O'Connor R Diaz RF Minasi P Wara WM Ocular toxoplasmosis in immunosuppressed nonhuman primates Invest Ophthalmol Vis Sci 29 1988 835 842
33. Dutton GN McMenamin PG Hay J Cameron S The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis, part II: the morphology of the inflammatory changes Exp Eye Res 43 1986 545 560
34. Newman PE Ghosheh R Tabbara KF O'Connor R Stern W The role of hypersensitivity reactions to Toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates Am J Ophthalmol 94 1982 159 164
35. Webb RM Tabbara KF O'Connor GR Retinal vasculitis in ocular toxoplasmosis in nonhuman primates Retina 4 1984 182 188
36. Hafizi A Modabber FZ Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization Clin Exp Immunol 33 1978 389 394
37. Hay J Aitken PP Hutchison WM Graham DI The effect of congenital and adult-acquired Toxoplasma infections on the motor performance of mice Ann Trop Med Parasitol 77 1983 261 277
38. Hutchison JH Lee WR Siim JC A study of cataract in murine congenital toxoplasmosis Ann Trop Med Parasitol 76 1982 53 70
39. Hay J Hutchison WM Lee WR Siim JC Cataract in mice congenitally infected with Toxoplasma gondii. Ann Trop Med Parasitol 75 1981 455 457
40. Culbertson WW Tabbara KF O'Connor GR Experimental ocular toxoplasmosis in primates Arch Ophthalmol 100 1982 321 323
41. Gazzinelli RT Oswald IP James SL Sher A IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages: IL-10 prevents IFN-γ from inducing activity against T. gondii and increasing production of RNIs by murine macrophages J Immunol 148 1992 1792 1796
42. Granstein RD Staszewski R Knisely TL Zeira E Nazareno R Latina M Aqueous humor contains transforming growth factor-β and -α small (<3500 daltons) inhibitor of thymocyte proliferation J Immunol 144 1990 3021 3027
43. Ksander BR Streilein JW Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites J Immunol 145 1990 2057 2063
44. Streilein JW Cousins SW Aqueous humor factors and their effect on the immune response in the anterior chamber Curr Eye Res 9 1990 175 182
45. Streilein JW Niederkorn JY Shadduck JA Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens J Exp Med 152 1980 1121 1125
46. Streilein JW Wilbanks GA Cousins SW Immunoregulatory mechanisms of the eye J Neuroimmunol 39 1992 185 200
47. Geiger K Howes EL Sarvetnick N Ecotopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections J Virol 68 1994 5556 5567
48. Suzuki Y Conley FK Remington JS Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon Infect Immun 58 1990 3050 3055